Evidence map›Paper›PMID 40387025›Full record

ArticleThe New England journal of medicine2025

Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.

Robert J Lentz, Katherine Frederick-Dyer, Virginia B Planz, Tatsuki Koyama, Matthew C Aboudara, Sameer K Avasarala, Jonathan D Casey, George Z Cheng, Pierre-François D'Haese, Jennifer D Duke and 19 more

2 registry-linked trialsAbstract readComparative StudyEquivalence TrialMulticenter Study
In one paragraph

Article in The New England journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04250194 nacompletednot on this map

Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration, a Randomized Controlled Study (VERITAS)

TypeinterventionalSponsorVanderbilt-Ingram Cancer CenterRan2020 to 2024Enrolled288ConditionsLung NoduleArmsCT-Guided Biopsy, Navigation bronchoscopy
NCT07685977 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Advanced Robotic Techniques and Rapid Onsite Evaluation for Minimally Invasive Diagnosis and Next-Generation Sequencing: the ARTEMIS Trial.

TypeinterventionalSponsorVanderbilt University Medical CenterRan2026 to 2029Enrolled400ConditionsPeripheral Pulmonary Lesions (PPLs)ArmsRapid onsite evaluation
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Robert J LentzDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.
Katherine Frederick-DyerDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville.ORCID 0000-0002-3281-1452
Virginia B PlanzDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville.
Tatsuki KoyamaDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville.
Matthew C AboudaraDivision of Pulmonary and Critical Care Medicine, St. Luke's Health System, University of Missouri at Kansas City, Kansas City.
Sameer K AvasaralaDivision of Pulmonary, Critical Care, and Sleep Medicine, University Hospitals, Case Western Reserve University School of Medicine, Cleveland.
Jonathan D CaseyDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.ORCID 0000-0001-7188-4200
George Z ChengDivision of Pulmonary, Critical Care, Sleep Medicine, and Physiology, University of California at San Diego, La Jolla.
Pierre-François D'HaeseVanderbilt University School of Engineering, Nashville.
Jennifer D DukeDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.
Eric L GroganDepartment of Thoracic Surgery, Vanderbilt University Medical Center, Nashville.
Todd C HoopmanKootenai Clinic Lung and Asthma, Kootenai Health, Coeur d'Alene, ID.
Joyce JohnsonDepartment of Pathology, Vanderbilt University Medical Center, Nashville.
James M KatsisDivision of Pulmonary, Critical Care, and Sleep Medicine, Rush University Medical Center, Chicago.
Jonathan S KurmanDivision of Pulmonary, Critical Care, and Sleep Medicine, Medical College of Wisconsin, Milwaukee.
See-Wei LowDivision of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland.
Kamran MahmoodDivision of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine, Durham, NC.
Otis B RickmanChest and Lung Center, Ascension Saint Thomas, Nashville.
Lance RollerDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.
Cristina SalmonDivision of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine, Durham, NC.
Samira ShojaeeDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.
Briana SwannerDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.
Momen M WahidiDivision of Pulmonary and Critical Care, Northwestern Feinberg School of Medicine, Chicago.
Charla WalstonChest and Lung Center, Ascension Saint Thomas, Nashville.
Gerard A SilvestriDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston.
Lonny YarmusDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore.
Najib M RahmanOxford Respiratory Trials Unit, University of Oxford, Oxford, United Kingdom.
Fabien MaldonadoDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville.
Interventional Pulmonary Outcomes Group

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)U24TR004437 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Gordon Raphael Bernard, Jonathan Dale Casey · 2023 to 2026
$19.9M
Validation of Biomarkers of Risk for the Early Detection of Lung CancerU01CA152662 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DEPPEN, STEPHEN, GROGAN, ERIC L · 2010 to 2025
$12.8M
Medtronic ERP-2018-11623NCATS NIH HHS U24 TR004437NCATS NIH HHS UL1 TR002243NCI NIH HHS U01 CA152662NIH HHS U01 CA152662 (Eric Grogan)
6 · The paper itself

Abstract

backgroundEach year, millions of pulmonary nodules are identified incidentally or through lung cancer screening, and many involve biopsy to distinguish cancer from benign processes. Both navigational bronchoscopy and computed tomography-guided transthoracic needle biopsy are commonly used in patients undergoing biopsies of peripheral pulmonary nodules, but the relative diagnostic accuracy of these two approaches is unclear.

methodsIn this multicenter, randomized, parallel-group, noninferiority trial, we assigned patients with an intermediate-risk or high-risk peripheral pulmonary nodule measuring 10 to 30 mm in diameter to undergo navigational bronchoscopy or transthoracic needle biopsy at seven centers across the United States. The primary outcome was diagnostic accuracy, which was defined as the percentage of patients with biopsies that showed a specific diagnosis (cancer or a specific benign condition) that was confirmed to be accurate through 12 months of clinical follow-up (nonferiority margin, 10 percentage points). Secondary outcomes included procedural complications such as the occurrence of pneumothorax.

resultsAmong the 234 patients included in the primary-outcome analysis (5 of whom were lost to follow-up), biopsy resulted in a specific diagnosis that was confirmed to be accurate through month 12 in 94 of 119 patients (79.0%) in the navigational bronchoscopy group and in 81 of 110 patients (73.6%) in the transthoracic needle biopsy group (absolute difference, 5.4 percentage points; 95% confidence interval, -6.5 to 17.2; P = 0.003 for noninferiority; P = 0.17 for superiority). Pneumothorax occurred in 4 of 121 patients (3.3%) in the navigational bronchoscopy group and in 32 of 113 patients (28.3%) in the transthoracic needle biopsy group and led to the placement of a chest tube, hospital admission, or both in 1 patient (0.8%) and 13 patients (11.5%), respectively.

conclusionsThe diagnostic accuracy of navigational bronchoscopy was noninferior to that of transthoracic needle biopsy among patients with peripheral pulmonary nodules measuring 10 to 30 mm. (Funded by Medtronic and others; VERITAS ClinicalTrials.gov number, NCT04250194.).

Indexed as

BronchoscopyImage-Guided BiopsyLung NeoplasmsMultiple Pulmonary NodulesSolitary Pulmonary NoduleAgedBiopsy, NeedleChest TubesFemaleHospitalizationHumansLungMaleMiddle AgedPneumothoraxTomography, X-Ray Computed

Identifiers

PMID40387025
PMCPMC12640718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.